News

Anumana Collaborates with Leading Global Health Care Company to Detect Heart Disease Using Artificial Intelligence

Novartis Pharmaceuticals Corporation to collaborate on development of new medical device software for earlier detection and intervention in cardiovascular disease…

2 years ago

Model N Announces Date of Third Quarter Fiscal Year 2022 Financial Results

SAN MATEO, Calif.--(BUSINESS WIRE)--Model N, Inc. (MODN), a leader in revenue optimization and compliance, plans to announce financial results for…

2 years ago

Synchron Appoints Kurt Haggstrom as Chief Commercial Officer

NEW YORK--(BUSINESS WIRE)--Synchron, an endovascular brain-computer (BCI) interface company, today announced the appointment of Kurt Haggstrom as Chief Commercial Officer.…

2 years ago

Hologic Showcases Advances across the Continuum of Breast Health at ECR 2022

--Global Leader in Women's Health Highlights Importance of Timely and Accurate Diagnosis-- MARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #3DMammography--Hologic, Inc. (Nasdaq: HOLX) will…

2 years ago

Resaphene Suisse AG: FDA Approval Process for Tinnitus Therapy Tinniwell Continues

ROGGWIL, Switzerland--(BUSINESS WIRE)--Due to the COVID pandemic, work for the FDA approval of the tinniwell was stopped at the beginning…

2 years ago

Tebra Names Kevin Marasco as Chief Marketing Officer

SaaS Veteran to Lead Marketing Efforts for All-in-One Solution for Independent Practices NEWPORT BEACH, Calif.--(BUSINESS WIRE)--#EHR--Tebra, the digital backbone for…

2 years ago

Glaukos to Release Second Quarter 2022 Financial Results after Market Close on August 3

Conference Call and Webcast Scheduled for 1:30 p.m. PT ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology…

2 years ago

XVIVO Presents Interim Report January-June 2022

GOTHENBURG, SWEDEN / ACCESSWIRE / July 13, 2022 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Strong sales growth and increased gross marginsSecond quarter…

2 years ago

Relief Signs a Definitive Agreement to Acquire a Novel Dosage Form of an Already Approved Prescription Drug for the Treatment of PKU

Company acquires an additional therapeutic product for the management of patients with PKU for worldwide markets, with the exception of…

2 years ago

NextGen Healthcare to Host Fiscal 2023 First Quarter Results Conference Call on July 26

ATLANTA--(BUSINESS WIRE)--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced that it will…

2 years ago